Contrasting toxicokinetic evaluations and interspecies pharmacokinetic scaling approaches for small molecules and biologics: applicability to biosimilar development

References

• Akabane T, Tabata K, Kadono K, Sakuda S, Terashita S, Teramura T. (2010). A comparison of pharmacokinetics between humans and monkeys. Drug Metab Dispos 38:308–316.
   PubMed Web of Science ®Google Scholar
• Boxenbaum H. (1984). Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab Rev 15:1071–1121.
   PubMed Web of Science ®Google Scholar
• Boxenbaum H. (1986). Time concepts in physics, biology, and pharmacokinetics. J Pharm Sci 75:1053–1062.
   PubMed Web of Science ®Google Scholar
• Boxenbaum H, Fertig JB. (1984). Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. Eur J Drug Metab Pharmacokinet 9:177–183.
   PubMed Web of Science ®Google Scholar
• Boxenbaum H, Ronfeld R. (1983). Interspecies pharmacokinetic scaling and the Dedrick plots. Am J Physiol 245:R768–R775.
   PubMed Web of Science ®Google Scholar
• Datamonitor. (2008). Biosimilars Series: Stakeholder Analysis - A Panoramic View of the Emerging Biosimilar Landscape. Report # DMHC2426.
   Google Scholar
• Datamonitor. (2009). Biosimilars series: Forecast analysis- Beyond the generics horizon. Report # DMHC2477.
   Google Scholar
• Dedrick R, Bischoff KB, Zaharko DS. (1970). Interspecies correlation of plasma concentration history of methotrexate (NSC-740). Cancer Chemother Rep 54:95–101.
   PubMedGoogle Scholar
• Deng R, Iyer S, Theil FP, Mortensen DL, Fielder PJ, Prabhu S. (2011). Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data: what have we learned? MAbs 3:61–66.
   PubMed Web of Science ®Google Scholar
• Dong JQ, Salinger DH, Endres CJ, Gibbs JP, Hsu CP, Stouch BJ, Hurh E, Gibbs MA. (2011). Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human prediction. Clin Pharmacokinet 50:131–142.
   PubMed Web of Science ®Google Scholar
• Espié P, Tytgat D, Sargentini-Maier ML, Poggesi I, Watelet JB. (2009). Physiologically based pharmacokinetics (PBPK). Drug Metab Rev 41:391–407.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency (EMA). (2006). Guideline on similar biological medicinal products containing biotechnology-derived proteins as active substances: non-clinical and clinical issues. European Medicines Agency, Committee for Medicinal Products for Human Use. EMEA/CHMP/BMWP/42832/2005. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003920.pdf. Accessed on 5 March 2012.
   Google Scholar
• European Medicines Agency (EMA). Scientific Guidelines on Biosimilars. (2012). Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000408.jsp&mid=WC0b01ac058002958c&jsenabled=true. Accessed on 15 March 2012.
   Google Scholar
• Gayon J. (2000). History of the concept of allometry. Am Zool 40:748–758.
   Google Scholar
• Huh Y, Smith DE, Feng MR. (2011). Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs. Xenobiotica 41:972–987.
   PubMed Web of Science ®Google Scholar
• IDEC Pharmaceutical Corp. (1997) Rituximab, Biologic license Application: Preclinical and Clinical Pharmacology Review. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm093352.htm. Accessed on 5 March 2012.
   Google Scholar
• Kleiber M. (1932). Body size and metabolism. Hilgardia 6:315–353.
   Google Scholar
• Ling J, Zhou H, Jiao Q, Davis HM. (2009). Interspecies scaling of therapeutic monoclonal antibodies: initial look. J Clin Pharmacol 49:1382–1402.
   PubMed Web of Science ®Google Scholar
• Mahmood I. (2009a). Role of fixed coefficients and exponents in the prediction of human drug clearance: how accurate are the predictions from one or two species? J Pharm Sci 98:2472–2493.
   PubMed Web of Science ®Google Scholar
• Mahmood I. (2009b). Pharmacokinetic allometric scaling of coagulation factors and tissue-type plasminogen activators. Haemophilia 15:1109–1117.
   PubMed Web of Science ®Google Scholar
• Mahmood I. (2009c). Pharmacokinetic allometric scaling of antibodies: application to the first-in-human dose estimation. J Pharm Sci 98:3850–3861.
   PubMed Web of Science ®Google Scholar
• Mahmood I, Balian JD. (1996). Interspecies scaling: predicting clearance of drugs in humans. Three different approaches. Xenobiotica 26:887–895.
   PubMed Web of Science ®Google Scholar
• Mahmood I, Yuan R. (1999). A comparative study of allometric scaling with plasma concentrations predicted by species-invariant time methods. Biopharm Drug Dispos 20:137–144.
   PubMed Web of Science ®Google Scholar
• Mascelli MA, Zhou H, Sweet R, Getsy J, Davis HM, Graham M, Abernethy D. (2007). Molecular, biologic, and pharmacokinetic properties of monoclonal antibodies: impact of these parameters on early clinical development. J Clin Pharmacol 47:553–565.
   PubMed Web of Science ®Google Scholar
• Mordenti J, Chen SA, Moore JA, Ferraiolo BL, Green JD. (1991). Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm Res 8:1351–1359.
   PubMed Web of Science ®Google Scholar
• Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P. (1997). The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. J Pharmacol Exp Ther 283:46–58.
   PubMed Web of Science ®Google Scholar
• Oitate M, Nakayama S, Ito T, Kurihara A, Okudaira N, Izumi T. (2012). Prediction of human plasma concentration-time profiles of monoclonal antibodies from monkey data by a species-invariant time method. Drug Metab Pharmacokinet 27:354–359.
   PubMed Web of Science ®Google Scholar
• Ring BJ, Chien JY, Adkison KK, Jones HM, Rowland M, Jones RD, Yates JW, Ku MS, Gibson CR, He H, Vuppugalla R, Marathe P, Fischer V, Dutta S, Sinha VK, Bjornsson T, Lave T, Poulin P. (2011). PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: Comparative assessement of prediction methods of human clearance. J Pharm Sci. 100:4074–4089.
   Google Scholar
• Schellekens H. (2009). Biosimilar therapeutics-what do we need to consider? NDT Plus 2:i27–i36.
   PubMedGoogle Scholar
• Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E. (2007). Interspecies prediction of human drug clearance based on scaling data from one or two animal species. Drug Metab Dispos 35:1886–1893.
   PubMed Web of Science ®Google Scholar
• Thygesen P, Macheras P, Van Peer A. (2009). Physiologically-based PK/PD modelling of therapeutic macromolecules. Pharm Res 26:2543–2550.
   PubMed Web of Science ®Google Scholar
• U.S. Food and Drug Administration (US FDA). Bioavailability and BioequivalenceStudies for Orally Administered Drug Products - General Considerations. (2003). Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070124.pdf. Accessed on 9 September 2012.
   Google Scholar
• U.S. Food and Drug Administration (US FDA). Draft Guidances for Biosimilars. (2012). Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/Biosimilars/default.htm. Accessed on 15 March 2012.
   Google Scholar
• Wajima T, Fukumura K, Yano Y, Oguma T. (2003). Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: volume of distribution at steady state. J Pharm Pharmacol 55:939–949.
   PubMed Web of Science ®Google Scholar
• Wajima T, Yano Y, Fukumura K, Oguma T. (2004). Prediction of human pharmacokinetic profile in animal scale up based on normalizing time course profiles. J Pharm Sci 93:1890–1900.
   PubMed Web of Science ®Google Scholar
• Wang W, Prueksaritanont T. (2010). Prediction of human clearance of therapeutic proteins: simple allometric scaling method revisited. Biopharm Drug Dispos 31:253–263.
   PubMed Web of Science ®Google Scholar
• West GB, Brown JH. (2005). The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J Exp Biol 208:1575–1592.
   PubMed Web of Science ®Google Scholar
• Woo S, Jusko WJ. (2007). Interspecies comparisons of pharmacokinetics and pharmacodynamics of recombinant human erythropoietin. Drug Metab Dispos 35:1672–1678.
   PubMed Web of Science ®Google Scholar